BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 7574490)

  • 1. Generation, translocation, and presentation of MHC class I-restricted peptides.
    Heemels MT; Ploegh H
    Annu Rev Biochem; 1995; 64():463-91. PubMed ID: 7574490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional regulation of immunoproteasomes and transporter associated with antigen processing.
    Hwang LY; Lieu PT; Peterson PA; Yang Y
    Immunol Res; 2001; 24(3):245-72. PubMed ID: 11817324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.
    Momburg F; Ortiz-Navarrete V; Neefjes J; Goulmy E; van de Wal Y; Spits H; Powis SJ; Butcher GW; Howard JC; Walden P
    Nature; 1992 Nov; 360(6400):174-7. PubMed ID: 1299222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing and delivery of peptides presented by MHC class I molecules.
    Lehner PJ; Cresswell P
    Curr Opin Immunol; 1996 Feb; 8(1):59-67. PubMed ID: 8729447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory proteins that control the assembly of MHC molecules with peptides.
    Van Kaer L
    Immunol Res; 2001; 23(2-3):205-14. PubMed ID: 11444385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules.
    Arnold D; Driscoll J; Androlewicz M; Hughes E; Cresswell P; Spies T
    Nature; 1992 Nov; 360(6400):171-4. PubMed ID: 1436094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
    Lautscham G; Rickinson A; Blake N
    Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
    Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
    J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.
    Reits E; Griekspoor A; Neijssen J; Groothuis T; Jalink K; van Veelen P; Janssen H; Calafat J; Drijfhout JW; Neefjes J
    Immunity; 2003 Jan; 18(1):97-108. PubMed ID: 12530979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.
    Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM
    J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.
    Neisig A; Roelse J; Sijts AJ; Ossendorp F; Feltkamp MC; Kast WM; Melief CJ; Neefjes JJ
    J Immunol; 1995 Feb; 154(3):1273-9. PubMed ID: 7822796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis and class I major histocompatibility complex antigen presentation.
    York IA; Goldberg AL; Mo XY; Rock KL
    Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway.
    Song R; Harding CV
    J Immunol; 1996 Jun; 156(11):4182-90. PubMed ID: 8666786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peptide-loading complex--antigen translocation and MHC class I loading.
    Schölz C; Tampé R
    Biol Chem; 2009 Aug; 390(8):783-94. PubMed ID: 19426129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating MHC class I ligands from viral gene products.
    Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
    Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways.
    Grommé M; Neefjes J
    Mol Immunol; 2002 Oct; 39(3-4):181-202. PubMed ID: 12200050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.